Healthcare Unfiltered
Healthcare Unfiltered is an honest, raw, timely podcast tackling any and all topics in healthcare that affect stakeholders. Dr. Chadi Nabhan uses his dynamic conversational skills to challenge his guests to address controversial and important topics. He also brings on world renowned experts to discuss clinical advances in medicine.
Episodes
271 episodes
Episode 272: Genomics for Rare Diseases With Katherine Stueland
Chadi sits down with Katherine Stueland, President and CEO of GeneDx, to explore how genomic sequencing is transforming the diagnosis of rare diseases—especially for pediatric patients who often endure years searching for answers. She discusses...
•
38:10
Episode 271: Behind the Scenes of “The Pitt” With Sylvia Owusu-Ansah
Chadi sits down with Dr. Sylvia Owusu-Ansah, a pediatric emergency physician at UPMC, to discuss her role as a medical advisor for the HBO Max series “The Pitt” and how she helped bring real-world authenticity to the show. She explains how the ...
•
47:09
Episode 270: Translational Research Questions in Small Cell Lung Cancer
Chadi sits down with Misty Shields, MD, PhD, Assistant Professor of Clinical Medicine in the Division of Hematology/Oncology at Indiana University School of Medicine, to explore the evolving translational research landscape in small cell lung c...
•
40:09
Episode 269: The Pain Brokers and Tort Law With Beth Burch
Chadi sits down with award-winning legal scholar Elizabeth (Beth) Chamblee Burch to explore “The Pain Brokers: How Con Men, Call Centers, and Rogue Doctors Fuel America’s Lawsuit Factory,” her deeply reported investigation into a multilevel sca...
•
48:00
Episode 268: Everything ADCs in Cancer With Paolo Tarantino
Paolo Tarantino, MD, PhD, medical oncologist at Dana-Farber Cancer Institute, joins Chadi for a deep dive into the rapidly evolving world of antibody-drug conjugates (ADCs)—sometimes dubbed “super-chemotherapies.” He traces the fascinating orig...
•
35:30
Episode 267: State of Peer Review and Medical Publishing With Nora Disis
Chadi sits down with Nora Disis, MD—Editor in Chief of JAMA Oncology and professor at Fred Hutchinson Cancer Center—for a candid, wide-ranging discussion on the modern state of peer review and medical publishing. Dr. Disis reflects on the found...
•
58:02
Episode 266 - History of Viruses: Kill Switch
Award-winning stem cell transplant pioneer, Dr. Richard Burt, discusses his book “Kill Switch: The History of How Viruses Shaped Humanity and Led to COVID-19,” guiding listeners through the deep, often surprising role viruses like smallpox, pol...
•
1:08:42
Episode 265: ASCO GI Updates: Special Episode
Drs. Shaalan Beg, Shruti Patel, and Emil Lou—the “Only Oncologists in the Building”—offer an in-depth, clinically focused review of the most important research presented at the ASCO GI Annual Meeting. The conversation spans the rising incidence...
•
58:07
Episode 264: Oncology Career Paths With the Two Onc Docs
In this cross-collaboration episode, Drs. Sam Armstrong and Karine Tawagi—hosts of the “Two Onc Docs” podcast—join the show to share their personal journeys into oncology and the inspiration behind launching a podcast for the oncology community...
•
55:01
Episode 263: ADCs in Breast Cancer: What to Know With VK Gadi
VK Gadi, MD, PhD, of the University of Illinois Cancer Center, joins the show for a deep dive into antibody-drug conjugates (ADCs) in breast cancer, tracing the history and basic science that fueled their development and early interest in the f...
•
36:27
Episode 262: MRD and ctDNA in Lymphoma With Megan Melody
Returning guest Megan Melody, MD—lymphoma and CAR-T hematologist at Tampa General Hospital and the University of South Florida—joins the show for a practical, data-driven discussion on the evolving role of measurable residual disease (MRD) and ...
•
48:06
Episode 261: Rebooting Cancer Care With Doug Flora
Returning guest Doug Flora, MD, LSSBB, practicing oncologist and healthcare innovator, joins the show to discuss his new book Rebooting Cancer Care and his pragmatic vision for how artificial intelligence is reshaping oncology today. Dr. Flora ...
•
40:59
Episode 260: TNBC Now and the Future With Greg Vidal
Chadi sits down with Gregory Vidal, MD, PhD, medical oncologist at the West Cancer Center, for a comprehensive, state-of-the-field discussion on triple-negative breast cancer (TNBC). Dr. Vidal walks listeners through how TNBC emerged as a diagn...
•
34:41
Episode 259: AI Enhancing Cancer Diagnosis With Jonathan Chen
Jonathan Chen, MD, PhD—Assistant Professor of Medicine and Biomedical Informatics at Stanford University—joins the show and offers a pragmatic look at how data science and AI can be meaningfully integrated into everyday medical practice. He bre...
•
36:18
Episode 258: AI Now and Later With Sanjay Juneja
Chadi sits down with Sanjay Juneja, MD—board-certified hematologist/oncologist, healthcare futurist, and physician executive—to demystify artificial intelligence and explain what it truly means for patient care today and in the years ahead. Dr....
•
53:53
Episode 257: Reflections of an ASCO President With Robin Zon
In this reflective and wide-ranging conversation, ASCO President Robin Zon, MD, FACP, FASCO, looks back on the formative moments that led her to oncology and the grit required to build a thriving community-based research program while balancing...
•
49:47
Episode 256: Managing Hodgkin Lymphoma in 2026
Chadi sits down with Dr. Sairah Ahmed just ahead of the ASH Annual Meeting for a comprehensive deep dive into the state of Hodgkin Lymphoma management in 2026. Dr. Ahmed walks through how clinicians should interpret the newest data releases, re...
•
34:56
Episode 255: AI and Healthcare: A Patient and a Caregiver Perspective
Journalist Erin O’Hearn joins Chadi to share her deeply personal story as both a patient and a caregiver navigating the healthcare system for more than two decades. Drawing from her lived experiences, Erin reflects on how today’s advances in ar...
•
43:46
Episode 254: Innovation in Community Oncology With COA President Debra Patt
Chadi sits down with Dr. Debra Patt, Executive Vice President of Texas Oncology and President of the Community Oncology Alliance (COA), for an in-depth conversation about the evolving landscape of community oncology. Dr. Patt outlines her visio...
•
46:00
Episode 253: Advances in Mutation-Driven Lung Cancer
Chadi resumes his WCLC review with Dr. Eric Singhi of The University of Texas MD Anderson Cancer Center, exploring the most significant updates in mutation-driven lung cancer presented at this year’s meeting. The discussion dives into advances ...
•
35:28
Episode 252: Advances in Non-Mutation Driven and Small Cell Lung Cancer
Dr. Estelamari Rodriguez, thoracic oncologist at the University of Miami’s Sylvester Comprehensive Cancer Center, joins the show to break down the latest advances in non-mutation driven and small cell lung cancer presented at the World Conferen...
•
44:52
Episode 251: Low-Risk MDS: What To Do?
Returning guest Dr. Amer Zeidan of Yale Medicine and Smilow Cancer Hospital joins to discuss how clinicians should approach low-risk Myelodysplastic Syndrome (MDS), which is most often managed in community settings. He breaks down how to risk-s...
•
46:39
Episode 250: Lung Cancer Updates From a Patient Perspective
Returning guest Jill Feldman, a prominent lung cancer survivor and patient advocate, shares her reflections on the World Conference on Lung Cancer (WCLC) from a patient’s point of view. She discusses how patients and advocates interpret complex...
•
42:58
Episode 249: No More Tears: A Fascinating Book on J&J
Investigative journalist and New York Times bestselling author Gardiner Harris joins the podcast to dive deep into his groundbreaking book, “No More Tears: The Dark Secrets of Johnson & Johnson.” Harris recounts the extensive research and c...
•
1:06:04
Episode 248: The Truth About 340B With Anthony DiGiorgio
Returning guest Anthony DiGiorgio, DO, a practicing neurosurgeon at UCSF and noted health policy commentator, takes a deep dive into the 340B Drug Pricing Program—one of the most consequential yet misunderstood mechanisms in US healthcare. He t...
•
35:54